Aerami Therapeutics
Aerami Therapeutics is focused on the development of inhaled therapeutics for cardiopulmonary and cardiometabolic diseases, including using its proprietary hand-held, electronic, connected, vibrating-mesh nebuliser, AFINA™.
Aerami Therapeutics is focused on the development of inhaled therapeutics for cardiopulmonary and cardiometabolic diseases, including using its proprietary hand-held, electronic, connected, vibrating-mesh nebuliser, AFINA™.
The company is privately owned. It began operations in 2010 as Dance, founded by Dr John Patton, who has more than 20 years of experience in the development of inhaled insulin.
